This week we start with a look at the potential for gene and cell therapy to radically change health care over the coming decade. Although there are few approved drugs using these technologies today, the pipeline of candidates in all phases of clinical studies is full of potential cell and gene therapy ... READ MORE >
clinical trials
5 things to know in life sciences: Week of May 24
Over the past year, there has been a simmering dispute between hospitals and pharmaceutical companies over the 340B drug pricing program. This week, the United States Department of Health and Human Services weighed in strongly on the side of the hospitals. We also look at the discussion at the World Trade ... READ MORE >
5 things to know in life sciences: Week of March 8
This week we look to make sense of COVID-19 variants. We also examine what appears to be heightened scrutiny on accelerated approvals for some treatments, gaps in the understanding of racial and ethnic representation in vaccine trials, tiny cancer-fighting robots and a new contract development and ... READ MORE >
5 things to know in life sciences: Week of Feb. 15
In this week’s roundup we look at promising results in a clinical trial leveraging an existing diabetes drug for the treatment of obesity, a new and less invasive treatment for sleep apnea, and a new technology in cardiac catheters. We also examine the impact of the pandemic on oncology trials and the ... READ MORE >